Acadia Appoints Board Member
This article was originally published in Scrip
Acadia Pharmaceuticals Inc. has appointed Edmund P. Harrigan to its board of directors. Currently Harrigan serves on the board of directors of Karuna Pharmaceuticals Inc. Previously he was senior vice president of worldwide safety and regulatory for Pfizer and also held various executive leadership roles at the company, including head of worldwide business development, head of worldwide regulatory affairs and quality assurance, and head of neuroscience and ophthalmology. Prior to entering the pharma industry Harrigan was a practicing neurologist.
Register for our free email digests: